Revvity | PKI - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Agilent USD 608M 7M 2026-06
Align Technology USD 109.84M 13.88M 2026-06
Bio Techne USD 26.7M 68.9M 2026-06
Bio-Rad Laboratories USD 143.5M 10.4M 2026-06
Bruker USD 200.2M 68.9M 2026-06
Celltrion KRW 88.58B 9.9B 2026-03
Charles River Laboratories USD 140.98M 7.03M 2026-06
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 260M 1000K 2026-06
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Illumina USD 230M 12M 2026-06
Intuitive Surgical USD 1.92B 66.6M 2026-06
IQVIA Holdings USD 3.61B 31M 2026-06
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Laboratory Of America USD 688.5M 7.2M 2026-06
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Mesa Laboratories USD 5.25M 163K 2025-12
Mettler Toledo International USD 229.8M 1.08M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
OraSure Technologies USD 8.4M 2.23M 2026-06
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacific Biosciences Of California USD 19.22M 5.61M 2026-06
Pharma Mar EUR 38.93M 4.9M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
Quest Diagnostics USD 1.6B 98M 2026-06
Quidel USD 236.5M 7M 2026-06
Repligen USD 33.23M 1.42M 2026-06
Revvity USD 165.74M 3.94M 2026-06
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Waters USD 602M 498.22M 2026-03
Zealand Pharma A/S 171M 175.6M 2026-03
Zz Pientze Pharmaceu CNY 471.72M 14.67M 2026-06